Assessment of adverse drug reactions and intravenous incompatibilities in a tertiary care teaching hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253151Keywords:
Adverse drug reactions, Medication safety, Patient safety, High-risk medications, Intravenous incompatibilitiesAbstract
Background: Adverse drug reactions (ADRs) and intravenous (i.v.) incompatibilities are significant concerns in clinical practice due to their potential to compromise patient safety and treatment efficacy. This study aimed to evaluate the prevalence, types, and consequences of ADRs and i.v. incompatibilities in prescriptions from tertiary care hospitals. The study also aimed to identify the most frequently implicated drugs and conditions associated with these issues and suggest recommendations for improving prescribing practices.
Methods: A prospective observational study was conducted over one year in a tertiary care hospital. Data were collected from 1000 patients across various age groups and genders in tertiary care settings. Detailed demographic information, prescribing patterns of high-risk medications, department-specific distribution, i.v. incompatibilities, and specific ADRs were analyzed. The assessment criteria included adherence to STGs, identification of deviations, and analysis of potential consequences.
Results: The study revealed a significant prevalence of unacceptable deviations from standard treatment guidelines, particularly with medications such as pantoprazole and rabeprazole with domperidone. High-risk medications like anticoagulants, antiplatelets, insulin, chemotherapeutic agents, opioids, and corticosteroids were frequently prescribed, with notable department-specific variations. I.v. incompatibilities were common with chemotherapeutic agents and insulin, while specific ADRs were associated with chemotherapeutic agents, insulin, anticoagulants, and corticosteroids.
Conclusions: The findings highlight the need for improved prescribing practices and strict adherence to guidelines, especially for high-risk medications. Implementation of targeted interventions, enhanced training for healthcare providers, utilization of electronic systems, robust pharmacovigilance programs, patient education, and department-specific protocols are recommended to enhance patient safety and treatment outcomes in tertiary care settings.
Metrics
References
Ramanath K, Hymavathi R. Assessment of intravenous admixtures in hospitalized patients of a rural tertiary care teaching hospital. Am J Pharm Tech Res. 2012;2:533-43.
Bertsche T, Mayer Y, Stahl R, Hoppe-Tichy T, Encke J, Haefeli WE. Prevention of intravenous drug incompatibilities in an intensive care unit. Am J Health-Syst Pharm. 2008;65(19):1834-40. DOI: https://doi.org/10.2146/ajhp070633
Padmaja U, Adhikari P, Pereira P. A prospective analysis of adverse drug reactions in a South Indian Hospital. Online J Health Allied Sci. 2009;8(3).
Sriram S, Aishwarya S, Kumar AA, Moithu A, Sebastian A. Intravenous drug incompatibility in intensive care units-A comprehensive review. Innov Pharm Pharmacother. 2018;6:55-60.
Mosisa B, Negeri B, Bayisa G, Sado E, Fekadu G, Gebre M, et al. Assessment of Intravenous Drugs Admixtures Incompatibilities at Nekemte Referral Hospital, West Ethiopia. Am J Health Res. 2020;8(5):84-8. DOI: https://doi.org/10.11648/j.ajhr.20200805.12
Reis AM, Cassiani SH. Adverse drug events in an intensive care unit of a university hospital. Eur J Clin Pharmacol. 2011;67:625-32. DOI: https://doi.org/10.1007/s00228-010-0987-y
Aruna C, Nagaraju A, Swathi K, Deepak AS, Ramani BV, Purushothaman M. Errors in the intravenous drug administration in general medicine department of tertiary care teaching hospital. J Glob Trends Pharm Sci. 2015;6:2628-34.
Mendes JR, Lopes MC, Vancini-Campanharo CR, Okuno MF, Batista RE. Types and frequency of errors in the preparation and administration of drugs. Einstein. 2018;16:eAO4146. DOI: https://doi.org/10.1590/s1679-45082018ao4146
Sundaran S, Udayan A, Hareendranath K, Eliyas B, Ganesan B, Hassan A, et al. Study on the classification, causality, preventability and severity of adverse drug reaction using spontaneous reporting system in hospitalized patients. Pharmacy. 2018;6(4):108. DOI: https://doi.org/10.3390/pharmacy6040108
Fahimi F, Ariapanah P, Faizi M, Shafaghi B, Namdar R, Ardakani MT. Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study. Aust Crit Care. 2008;21(2):110-6. DOI: https://doi.org/10.1016/j.aucc.2007.10.004
Leopoldino RD, Santos MT, Costa TX, Martins RR, Oliveira AG. Risk assessment of patient factors and medications for drug-related problems from a prospective longitudinal study of newborns admitted to a neonatal intensive care unit in Brazil. BMJ Open. 2019;9(7):e024377. DOI: https://doi.org/10.1136/bmjopen-2018-024377
Al-Jeraisy MI, Alanazi MQ, Abolfotouh MA. Medication prescribing errors in a pediatric inpatient tertiary care setting in Saudi Arabia. BMC Res Notes. 2011;4:1-6. DOI: https://doi.org/10.1186/1756-0500-4-294
McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36(9):1331-6. DOI: https://doi.org/10.1345/aph.1A333
Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health-Syst Pharm. 2003;60(17):1750-9. DOI: https://doi.org/10.1093/ajhp/60.17.1750
Alomar MJ. Factors affecting the development of adverse drug reactions. Saudi Pharm J. 2014;22(2):83-94. DOI: https://doi.org/10.1016/j.jsps.2013.02.003
Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf. 2004;27:819-29. DOI: https://doi.org/10.2165/00002018-200427110-00005
Routledge PA. Adverse drug reactions and interactions: mechanisms, risk factors, detection, management and prevention. Stephens’ Detect New Adv Drug React. 2004;4. DOI: https://doi.org/10.1002/0470014199.ch2
Verma R, Vasudevan B, Pragasam V. Severe cutaneous adverse drug reactions. Med J Armed Forces India. 2013;69(4):375-83. DOI: https://doi.org/10.1016/j.mjafi.2013.01.007
Kumar BN, Nayak K, Singh H, Dulhani N, Singh P, Tewari P. A pharmacovigilance study in medicine department of tertiary care hospital in Chhattisgarh (Jagdalpur), India. J Young Pharm. 2010;2(1):95-100. DOI: https://doi.org/10.4103/0975-1483.62222
Hardmeier B, Braunschweig S, Cavallaro M, Roos M, Pauli-Magnus C, Giger M, et al. Adverse drug events caused by medication errors in medical inpatients. Swiss Med Week. 2004;134(45-46):664-70. DOI: https://doi.org/10.4414/smw.2004.10801
Lee HY, Tay LK, Thirumoorthy T, Pang SM. Cutaneous adverse drug reactions in hospitalised patients. Singapore Med J. 2010;51(10):767.
Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children- a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11:1-0. DOI: https://doi.org/10.1186/1741-7015-11-237
Gallagher RM, Mason JR, Bird KA, Kirkham JJ, Peak M, Williamson PR, et al. Adverse drug reactions causing admission to a paediatric hospital. PloS One. 2012;7(12):e50127. DOI: https://doi.org/10.1371/journal.pone.0050127
Pattanaik S, Dhamija P, Malhotra S, Sharma N, Pandhi P. Evaluation of cost of treatment of drug‐related events in a tertiary care public sector hospital in Northern India: a prospective study. Br J Clin Pharmacol. 2009;67(3):363-9. DOI: https://doi.org/10.1111/j.1365-2125.2008.03346.x
Kulkarni V, Bora SS, Sirisha S, Saji M, Sundaran S. A study on drug-drug interactions through prescription analysis in a South Indian teaching hospital. Ther Adv Drug Saf. 2013;4(4):141-6. DOI: https://doi.org/10.1177/2042098613490009
Hisham M, Sivakumar MN, Veerasekar G. Impact of clinical pharmacist in an Indian intensive care unit. Indian J Crit Care Med. 2016;20(2):78. DOI: https://doi.org/10.4103/0972-5229.175931
Lima SI, Martins RR, Saldanha V, Silbiger VN, Dos Santos IC, Araújo IB, et al. Development and validation of a clinical instrument to predict risk of an adverse drug reactions in hospitalized patients. PLoS One. 2020;15(12):e0243714. DOI: https://doi.org/10.1371/journal.pone.0243714
Seynaeve S, Verbrugghe W, Claes B, Vandenplas D, Reyntiens D, Jorens PG. Adverse drug events in intensive care units: a cross-sectional study of prevalence and risk factors. Am J Crit Care. 2011;20(6):e131-40. DOI: https://doi.org/10.4037/ajcc2011818
Khandeparkar A, Rataboli PV. A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College. Perspect Clin Res. 2017;8(4):180-6. DOI: https://doi.org/10.4103/picr.PICR_132_16
Ong WM, Subasyini S. Medication errors in intravenous drug preparation and administration. Med J Malaysia. 2013;68(1):52-7.
Mittal N, Mittal R, Singh I, Shafiq N, Malhotra S. Drug utilisation study in a tertiary care center: Recommendations for improving hospital drug dispensing policies. Indian J Pharm Sci. 2014;76(4):308.
Aljadhey H, Mahmoud MA, Mayet A, Alshaikh M, Ahmed Y, Murray MD, et al. Incidence of adverse drug events in an academic hospital: a prospective cohort study. Int J Qual Health Care. 2013;25(6):648-55. DOI: https://doi.org/10.1093/intqhc/mzt075
Awortwe C, Makiwane M, Reuter H, Muller C, Louw J, Rosenkranz B. Critical evaluation of causality assessment of herb-drug interactions in patients. Br J Clin Pharmacol. 2018;84(4):679-93. DOI: https://doi.org/10.1111/bcp.13490
Silva AE, Reis AM, Miasso AI, Santos JO, Cassiani SH. Adverse drug events in a sentinel hospital in the State of Goiás, Brazil. Revi Latino-Am Enferm. 2011;19:378-86. DOI: https://doi.org/10.1590/S0104-11692011000200021
Mathews B, Thalody AA, Miraj SS, Kunhikatta V, Rao M, Saravu K. Adverse effects of fluoroquinolones: a retrospective cohort study in a South Indian tertiary healthcare facility. Antibiotics. 2019;8(3):104. DOI: https://doi.org/10.3390/antibiotics8030104
Suggett E, Marriott J. Risk factors associated with the requirement for pharmaceutical intervention in the hospital setting: a systematic review of the literature. Drugs-Real World Outcomes. 2016;3:241-63. DOI: https://doi.org/10.1007/s40801-016-0083-4
Kopp BJ, Erstad BL, Allen ME, Theodorou AA, Priestley G. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Crit Care Med. 2006;34(2):415-25. DOI: https://doi.org/10.1097/01.CCM.0000198106.54306.D7
Alghamdi AA, Keers RN, Sutherland A, Ashcroft DM. Prevalence and nature of medication errors and preventable adverse drug events in paediatric and neonatal intensive care settings: a systematic review. Drug Saf. 2019;42:1423-36. DOI: https://doi.org/10.1007/s40264-019-00856-9
Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285(16):2114-20. DOI: https://doi.org/10.1001/jama.285.16.2114
Downloads
Published
How to Cite
Issue
Section
